Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4060254
Max Phase: Preclinical
Molecular Formula: C29H36N5NaO10S
Molecular Weight: 647.71
Molecule Type: Small molecule
Associated Items:
ID: ALA4060254
Max Phase: Preclinical
Molecular Formula: C29H36N5NaO10S
Molecular Weight: 647.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNS(C)(=O)=O)O[C@@](OCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)(C(=O)[O-])C[C@@H]1O.[Na+]
Standard InChI: InChI=1S/C29H37N5O10S.Na/c1-18(35)31-25-23(36)15-29(28(39)40,44-27(25)26(38)24(37)16-30-45(2,41)42)43-14-6-13-34-17-22(32-33-34)21-11-9-20(10-12-21)19-7-4-3-5-8-19;/h3-5,7-12,17,23-27,30,36-38H,6,13-16H2,1-2H3,(H,31,35)(H,39,40);/q;+1/p-1/t23-,24+,25+,26+,27+,29+;/m0./s1
Standard InChI Key: JUZPERZWVAWITJ-IKXLCDCVSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 647.71 | Molecular Weight (Monoisotopic): 647.2261 | AlogP: -0.27 | #Rotatable Bonds: 14 |
Polar Surface Area: 222.43 | Molecular Species: ACID | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.86 | CX Basic pKa: | CX LogP: -0.12 | CX LogD: -3.61 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.12 | Np Likeness Score: -0.30 |
1. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.. (2017) Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion., 60 (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111] |
Source(1):